Flywire Corporation, together with its subsidiaries, operates as a payment enablement and software company in the United States, Europe, the Middle East, and Africa and the Asia Pacific.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 18.45, read 2026-11-03
Ethical passes the values gate
Price21.81 USD
Fair value25.00
Ethical score70.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-11Read Accumulation18.22+19.7% to today ✓Markdown gives way to Accumulation after a 6% rise in 9 days
2026-10-02Read Markdown17.12+27.4% to today Markup gives way to Markdown after an 8% slide in 5 weeks
2026-08-29Read Markup18.70+16.6% to today ✓Distribution gives way to Markup first Markup read since July
2026-07-30Read Distribution18.13+20.3% to today Markup gives way to Distribution after a 23% rise in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Flywire Corporation holds its Accumulation at $21.81. The statistical read favours the buyers, held for 103 days.
As held on the ledger · 2026-11-04
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 103 days
Price at the screen
$21.81
Valuation
35.75 trailing · 16.02 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.30
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.11%
Below 33%
Interest-bearing debt is just 0.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.97%
Below 33%
Cash held in interest-bearing accounts and securities is 2.0% of assets, under the one-third limit.
Pass
Receivables
29.13%
Below 49%
Money owed to the company is 29.1% of assets, under the 49% limit.
Pass
Revenue purity
0.91%
Below 5%
Only 0.9% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Flywire clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FLYW's ethical verdict changes
Today FLYW passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 13% discount to our $25.00 fair value, 27.20% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 12.8% discount to the base estimate.
Where our models see it going: fair-value estimate $25.00, with a range of $25.00 to $43.62, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Payments Platform With Growth But No Edge
Every time a student pays overseas tuition or a patient settles a medical bill across borders, Flywire sits in the middle trying to make the transfer smooth. The company has built a platform that slots into existing systems, and revenue is rising 41 percent a year. Yet we pass. Thin 4 percent profit margins and a 4 percent return on equity show the business is still not converting that growth into real owner earnings, and an unknown moat leaves the durability of those numbers open to question.
The shares trade at 14.5 times forward earnings with a modest premium to our fair value estimate. Thirteen analysts rate the stock a buy with a median target of 20 dollars, a touch above the current 18.13 dollar price. Those figures look reasonable on paper, but low returns on capital at this stage of the company's life usually signal either heavy reinvestment that has yet to pay off or simply limited pricing power.
The ethical screen is clear, which removes one common objection. Still, unknown competitive insulation and weak profitability metrics outweigh the surface growth rate. Without clearer evidence that returns will lift, the story stays unconvincing despite the clean bill on values.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FLYW trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Accumulation$19.49-1.0%Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Accumulation$19.69+0.0%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Accumulation$19.69+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Accumulation$19.69+2.1%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Accumulation$19.29+1.9%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Accumulation$18.93+1.6%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Accumulation$18.63+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Accumulation$18.63+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 26% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$18.63-3.7%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19.
2026-10-18Accumulation$19.35+6.2%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 19% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (14 analysts) rates it buy, with a mean price target of $19.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
